MX2021001393A - Composiciones para el tratamiento de la enfermedad de injerto contra huesped. - Google Patents
Composiciones para el tratamiento de la enfermedad de injerto contra huesped.Info
- Publication number
- MX2021001393A MX2021001393A MX2021001393A MX2021001393A MX2021001393A MX 2021001393 A MX2021001393 A MX 2021001393A MX 2021001393 A MX2021001393 A MX 2021001393A MX 2021001393 A MX2021001393 A MX 2021001393A MX 2021001393 A MX2021001393 A MX 2021001393A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- treatment
- host disease
- versus host
- graft versus
- Prior art date
Links
- 208000009329 Graft vs Host Disease Diseases 0.000 title abstract 2
- 208000024908 graft versus host disease Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18187409 | 2018-08-05 | ||
| PCT/EP2019/071026 WO2020030593A1 (en) | 2018-08-05 | 2019-08-05 | Compositions for the treatment of graft versus host disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021001393A true MX2021001393A (es) | 2021-04-12 |
Family
ID=63165229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021001393A MX2021001393A (es) | 2018-08-05 | 2019-08-05 | Composiciones para el tratamiento de la enfermedad de injerto contra huesped. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210290741A1 (https=) |
| EP (1) | EP3829552A1 (https=) |
| JP (1) | JP2021533150A (https=) |
| KR (1) | KR20210040395A (https=) |
| CN (1) | CN112689506A (https=) |
| AU (1) | AU2019320483A1 (https=) |
| BR (1) | BR112021002105A2 (https=) |
| CA (1) | CA3106433A1 (https=) |
| IL (1) | IL280589A (https=) |
| MX (1) | MX2021001393A (https=) |
| WO (1) | WO2020030593A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220218800A1 (en) * | 2019-05-06 | 2022-07-14 | Synthetic Biologics, Inc. | Beta-lactamase compositions for treatment of graft versus host disease |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006249100B2 (en) | 2005-05-18 | 2012-01-19 | Assistance Publique - Hospitaux De Paris | Colonic delivery of adsorbents |
| US8048413B2 (en) | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| FI119190B (fi) | 2006-06-21 | 2008-08-29 | Ipsat Therapies Oy | Modifioitu beta-laktamaasi ja menetelmä sen valmistamiseksi |
| MX340822B (es) | 2010-02-23 | 2016-07-26 | Da Volterra * | Formulaciones para suministro oral de adsorbentes en el intestino. |
| FI20105572A0 (fi) | 2010-05-24 | 2010-05-24 | Prevab R Lcc | Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt |
| EP2897594B1 (en) | 2012-09-21 | 2020-04-08 | Ferring B.V. | Pharmaceutical composition |
| US9290754B2 (en) | 2014-04-17 | 2016-03-22 | Synthetic Biologics Inc. | Beta-lactamases with improved properties for therapy |
| CN107148473B (zh) * | 2014-10-08 | 2021-08-06 | 合成生物制品有限公司 | β-内酰胺酶制剂及其用途 |
| FR3027307B1 (fr) | 2014-10-16 | 2016-11-04 | Azurrx Sas | Molecule proteique hybride apte a inhiber au moins un antibiotique et composition pharmaceutique la comportant |
| CA3254897A1 (en) * | 2014-11-25 | 2026-03-02 | Memorial Sloan-Kettering Cancer Center | Intestinal microbiota and gvhd |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
-
2019
- 2019-08-05 JP JP2021506287A patent/JP2021533150A/ja active Pending
- 2019-08-05 US US17/263,828 patent/US20210290741A1/en not_active Abandoned
- 2019-08-05 MX MX2021001393A patent/MX2021001393A/es unknown
- 2019-08-05 BR BR112021002105-1A patent/BR112021002105A2/pt not_active Application Discontinuation
- 2019-08-05 WO PCT/EP2019/071026 patent/WO2020030593A1/en not_active Ceased
- 2019-08-05 CA CA3106433A patent/CA3106433A1/en active Pending
- 2019-08-05 EP EP19746500.8A patent/EP3829552A1/en not_active Withdrawn
- 2019-08-05 CN CN201980050483.7A patent/CN112689506A/zh active Pending
- 2019-08-05 AU AU2019320483A patent/AU2019320483A1/en not_active Abandoned
- 2019-08-05 KR KR1020217005467A patent/KR20210040395A/ko not_active Ceased
-
2021
- 2021-02-02 IL IL280589A patent/IL280589A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN112689506A (zh) | 2021-04-20 |
| US20210290741A1 (en) | 2021-09-23 |
| JP2021533150A (ja) | 2021-12-02 |
| KR20210040395A (ko) | 2021-04-13 |
| BR112021002105A2 (pt) | 2021-06-01 |
| IL280589A (en) | 2021-03-25 |
| CA3106433A1 (en) | 2020-02-13 |
| AU2019320483A1 (en) | 2021-02-18 |
| EP3829552A1 (en) | 2021-06-09 |
| WO2020030593A1 (en) | 2020-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12022551013A1 (en) | Pyridazinones as parp7 inhibitors | |
| ZA202502750B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| PH12020551760A1 (en) | Pyridazinones as parp7 inhibitors | |
| MX2020001774A (es) | Composiciones y métodos para tratar enfermedad colestásica. | |
| MY205416A (en) | Tyk2 inhibitors and uses thereof | |
| PH12019501533A1 (en) | Tigit-and light-based chimeric proteins | |
| MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
| EA201891200A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| MX2018009773A (es) | Heteroarilos inhibidores de peptidilarginina desiminasa 4 (pad4). | |
| EA201891199A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| MX2019001471A (es) | Anticuerpos anti-siglec-7 para el tratamiento del cancer. | |
| EA201890047A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201890048A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| JOP20210158A1 (ar) | مُعَدِّلات التعبير الجيني عن hsd17b13 | |
| MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
| MX2020006365A (es) | Quinazolinonas como inhibidores de poli(adenosin difosfato-ribosa)polimerasa 14 (parp14). | |
| MX2018016057A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
| MX2022001310A (es) | Compuesto de fenil-2-hidroxi-acetilamino-2-metil-fenilo. | |
| WO2020021480A3 (en) | Compositions and methods for treating the eye | |
| PH12020551071A1 (en) | Compositions and methods for treating retinal disorders | |
| MX2020012990A (es) | Formulaciones de tegavivint y compuestos relacionados. | |
| MX2020002147A (es) | Composiciones útiles para la mejora del dolor. | |
| MX2021001393A (es) | Composiciones para el tratamiento de la enfermedad de injerto contra huesped. | |
| IL275384A (en) | Methods and compositions for pre-emptive treatment of graft versus host disease | |
| MA40642A (fr) | Nouveaux dérivés peptidiques et leurs utilisations |